42976-121-02 : NDC 2026 Code

42976-121-02 : Antithrombin Recombinant ( Atryn )

Additionally :

You can get information about “42976-121-02” NDC code in 42976-121-02 in HTML format

HTML | 42976-121-02 in TXT (Plain Text) format

TXT | 42976-121-02 in PDF (Portable Document Format)

PDF | 42976-121-02 in XML format

XML formats.

NDC Code : 42976-121-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "42976-121-02",
    "PackageDescription": "1 VIAL in 1 CARTON (42976-121-02)  &gt; 3 mL in 1 VIAL",
    "NDC11Code": "42976-0121-02",
    "ProductNDC": "42976-121",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Atryn",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Antithrombin Recombinant",
    "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20090506",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA125284",
    "LabelerName": "rEVO Biologics, Inc.",
    "SubstanceName": "ANTITHROMBIN ALFA",
    "StrengthNumber": "1750",
    "StrengthUnit": "[iU]/mL",
    "Pharm_Classes": "Decreased Coagulation Factor Activity [PE], Factor Xa Inhibitors [MoA], Recombinant Antithrombin [EPC], Thrombin Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2022-06-23",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20221231",
    "StartMarketingDatePackage": "20090506",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}